Related references
Note: Only part of the references are listed.LncRNA PVT1 promotes tumorigenesis of glioblastoma by recruiting COPS5 to deubiquitinate and stabilize TRIM24
Tao Lv et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It
Jiayu Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
MicroRNAs in oral fluids (saliva and gingival crevicular fluid) as biomarkers in orthodontics: systematic review and integrated bioinformatic analysis
Priyanka Kapoor et al.
PROGRESS IN ORTHODONTICS (2021)
lncRNA PVT1 in the Pathogenesis and Clinical Management of Renal Cell Carcinoma
Julia Bohosova et al.
BIOMOLECULES (2021)
LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p
Jie Wu et al.
Aging-US (2021)
Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
I. Resch et al.
ESMO OPEN (2021)
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data
Tianzhi Wu et al.
INNOVATION (2021)
Ferroptosis: Final destination for cancer?
Zeng Ye et al.
CELL PROLIFERATION (2020)
Tumor Immunology and Tumor Evolution: Intertwined Histories
Jerome Galon et al.
IMMUNITY (2020)
Outcomes Associated with First-Line anti-PD-1/PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Carlo Buonerba et al.
CANCERS (2020)
lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis
Yanni Yang et al.
AGING-US (2020)
Iron Metabolism, Ferroptosis, and the Links With Alzheimer's Disease
Nao Yan et al.
FRONTIERS IN NEUROSCIENCE (2020)
lncRNA 00312 Attenuates Cell Proliferation and Invasion and Promotes Apoptosis in Renal Cell Carcinoma via miR-34a-5p/ASS1 Axis
Jiawei Zeng et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Emerging Mechanisms and Disease Relevance of Ferroptosis
Brent R. Stockwell et al.
TRENDS IN CELL BIOLOGY (2020)
Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma
Yuenan Liu et al.
CELL DEATH & DISEASE (2020)
MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells
Chengcheng Gai et al.
CELL DEATH & DISEASE (2020)
The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma
Guobin Tan et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2020)
Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion
Yang Li et al.
CELL DEATH AND DIFFERENTIATION (2019)
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
Min Wang et al.
CELL DEATH AND DIFFERENTIATION (2019)
The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data
Bo Zhang et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
Mechanisms of immune-related adverse events associated with immune checkpoint blockade: using germline genetics to develop a personalized approach
Zia Khan et al.
GENOME MEDICINE (2019)
ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis
Liang Chen et al.
FRONTIERS IN ONCOLOGY (2019)
Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers
Jitwadee Inthagard et al.
CLINICAL SCIENCE (2019)
A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53
Chao Mao et al.
CANCER RESEARCH (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Ferroptosis and cell death mechanisms in Parkinson's disease
Stephanie J. Guiney et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration
William Sealy Hambright et al.
REDOX BIOLOGY (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
Edgardo D. Carosella et al.
EUROPEAN UROLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
Ninh M. La-Beck et al.
PHARMACOTHERAPY (2015)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)